CHE Chemed
- 547.960
- +4.960+0.91%
Chemed News
A Look At The Fair Value Of Chemed Corporation (NYSE:CHE)
How Is The Market Feeling About Chemed?
Chemed's (NYSE:CHE) short percent of float has risen 11.16% since its last report. The company recently reported that it has 312 thousand shares sold short, which is 2.39% of all regular shares that
Should You Keep Chemed (CHE) Stock in Your Portfolio Now?
$1000 Invested In This Stock 15 Years Ago Would Be Worth $14,000 Today
Chemed (NYSE:CHE) has outperformed the market over the past 15 years by 6.44% on an annualized basis producing an average annual return of 18.98%. Currently, Chemed has a market capitalization of $8.1
A Look At The Intrinsic Value Of Chemed Corporation (NYSE:CHE)
Key Insights Chemed's estimated fair value is US$630 based on 2 Stage Free Cash Flow to Equity Current share price of US$538 suggests Chemed is potentially trading close to its fair value
BofA Securities Maintains Chemed(CHE.US) With Buy Rating, Maintains Target Price $708
BofA Securities analyst Joanna Gajuk maintains $Chemed(CHE.US)$ with a buy rating, and maintains the target price at $708.According to TipRanks data, the analyst has a success rate of 57.0% and a
Chemed Corp: A Buy Rating With Strong Vitas Fundamentals and Growth in Roto-Rooter Services
Chemed To Report Second-Quarter 2024 Earnings July 24, Related Conference Call To Be Held On July 25
Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the second quarter ended June 30, 2024, on Wednesday, July 24, 2024, following the close of trading on the New York Stock
Should Weakness in Chemed Corporation's (NYSE:CHE) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
It is hard to get excited after looking at Chemed's (NYSE:CHE) recent performance, when its stock has declined 17% over the past three months. However, the company's fundamentals look pretty decent,
Investing in Chemed (NYSE:CHE) Five Years Ago Would Have Delivered You a 51% Gain
Insider Selling: Director Patrick Grace Sells Shares of Chemed Corp (CHE)
Chemed(CHE.US) Director Sells US$153.64K in Common Stock
$Chemed(CHE.US)$ Director GRACE PATRICK P sold 284 shares of common stock on Jun 12, 2024 at an average price of $540.98 for a total value of $153.64K.Source: Announcement What is statement of changes
(CHE) - Analyzing Chemed's Short Interest
Chemed's (NYSE:CHE) short percent of float has risen 15.52% since its last report. The company recently reported that it has 350 thousand shares sold short, which is 2.68% of all regular shares that a
Form 144 | Chemed(CHE.US) Director Proposes to Sell 154.28K in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 12, $Chemed(CHE.US)$ Director Patrick P. Grace intends to sell 284 shares of its common stock on Jun 12, with a total market value of approximately $154.28K. Source: An
Insider Sale: President and CEO Kevin Mcnamara Sells Shares of Chemed Corp (CHE)
Chemed(CHE.US) Officer Sells US$816.25K in Common Stock
$Chemed(CHE.US)$ Officer MCNAMARA KEVIN J sold 1,500 shares of common stock on Jun 6, 2024 at an average price of $544.17 for a total value of $816.25K.Source: Announcement What is statement of change
Chemed Insider Sold Shares Worth $816,255, According to a Recent SEC Filing
Kevin J McNamara, Director, President and CEO, on June 06, 2024, sold 1,500 shares in Chemed (CHE) for $816,255. Following the Form 4 filing with the SEC, McNamara has control over a total of 107,049
Form 144 | Chemed(CHE.US) Officer Proposes to Sell 820.5K in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 5, $Chemed(CHE.US)$ Officer MCNAMARA KEVIN J intends to sell 1,500 shares of its common stock on Jun 6, with a total market value of approximately $820.5K. MCNAMARA KEVIN
Why You Should Care About Chemed's (NYSE:CHE) Strong Returns On Capital
To find a multi-bagger stock, what are the underlying trends we should look for in a business? In a perfect world, we'd like to see a company investing more capital into its business and ideally the returns earned from that capital are also increasing.
Chemed Corporation to Present at the Jefferies 2024 Global Healthcare Conference
Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Jefferies 2024 Global Healthcare Conference on Wednesday, June 5, 2024, at approximately 9:00 a.m. (ET) at the New York Marriott
Analysis
Price Target
No Data
